Skip to content

Huajuxiaozhi Fang for Obesity with Liver Qi Stagnation and Spleen Deficiency: A Clinical Trial

Huajuxiaozhi Fang for Obesity with Liver Qi Stagnation and Spleen Deficiency: A Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000626
Enrollment
Unknown
Registered
2025-04-01
Start date
2025-04-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Control group:Basic treatment
Treatment group:Basic treatment+Huajuxiaozhi Fang

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the Western medical diagnostic criteria for obesity; (2) Be diagnosed with the pattern of liver qi stagnation and spleen deficiency according to Traditional Chinese Medicine (TCM); (3) Be aged =18 and =70 years with no gender restrictions; (4) The participant understands agrees to participate in this study and voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Secondary obesity caused by various reasons such as Cushing's syndrome hypothyroidism hypogonadism hypothalamic disorders or obesity induced by medications; (2) Patients with diabetes or those who have received antidiabetic drug treatment; (3) Low-density lipoprotein cholesterol =4.9 mmol/L or triglycerides =5.6 mmol/L; (4) Pregnant or breastfeeding women; (5) Patients with severe chronic diseases such as serious metabolic disorders cardiovascular and cerebrovascular diseases tumors or hepatic and renal insufficiency; (6) Patients with mental disorders; (7) Patients who have received traditional Chinese or Western medical treatment for obesity within the past month; (8) Individuals allergic to components of traditional Chinese medicine.

Design outcomes

Primary

MeasureTime frame
The difference in body mass index before and after treatment;

Secondary

MeasureTime frame
Cholesterol;Integral score of Traditional Chinese Medicine Syndrome Scale;2-hour postprandial insulin;2-hour postprandial blood glucose;TNF-a;Patient health questionnaire-9;hs-CRP;Glycated hemoglobin;High-density lipoprotein cholesterol;Eating disorder inventory;Free fatty acids;Triglycerides;Fasting insulin;Pittsburgh sleep quality inde;Waist-to-hip ratio;Visceral fat;IL-6;Ankle-branchial index;Fasting blood glucose;generalized anxiety disorder 7-item;Flow mediated dilation;Low-density lipoprotein cholesterol;Body fat percentage;Brachial- ankle pulse wave velocity;Waist-to-height ratio;Waist circumference;

Countries

China

Contacts

Public ContactHe Yanming

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine

heyanming176@163.com13386193310

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026